REGN
Regeneron Pharmaceuticals Inc.
$595.68
+$3.69(+0.62%)
75
Overall
80
Value
70
Tech
--
Quality
Market Cap
$62.74B
Volume
904.73K
52W Range
$476.49 - $1,154.56
Target Price
$729.50
EPS Estimates Overview
| Current Quarter | $7.65 | Next Quarter | $7.05 |
| Current Year | $30.85 | Next Year | $31.53 |
| QoQ Growth | -7.8% | YoY Growth | +2.2% |
| 3Y EPS CAGR | -18.8% | Target Price | $729.50 |
| Consensus | Buy | Upside | +22.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $595.68 | +0.6% | 904.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW